Table 2.
Characteristics of the implementation population
| Variable | Total Population | Group 1: No eGFR | Group 2: eGFR≥60 | Group 3: eGFR 45–59 | Group 4: eGFR 30–44 | Group 5: eGFR 15–29 | Group 6: eGFR<15 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | %/SD | N | %/SD | N | %/SD | N | %/SD | N | %/SD | N | %/SD | N | %/SD | |
| No. | 2,082,017 | 940,223 | 1,001,213 | 84,348 | 34,045 | 13,009 | 9170 | |||||||
| Age, yr | 50 | 19 | 45 | 18 | 51 | 17 | 70 | 14 | 74 | 14 | 71 | 15 | 62 | 16 |
| Women | 1,209,280 | 58% | 549,534 | 58% | 581,798 | 58% | 47,886 | 57% | 19,154 | 56% | 6854 | 53% | 4049 | 44% |
| Black | 181,742 | 9% | 65,481 | 7% | 104,267 | 10% | 5567 | 7% | 2768 | 8% | 1603 | 12% | 2055 | 22% |
| No. eGFR measurements | 6 | 17 | N/A | N/A | 7 | 15 | 16 | 29 | 24 | 44 | 31 | 54 | 35 | 68 |
| Days to most recent eGFR | 604 | 816 | N/A | N/A | 649 | 870 | 456 | 704 | 355 | 561 | 355 | 550 | 482 | 691 |
| Prior eGFR <60 | 178,099 | 9% | N/A | N/A | 79,812 | 8% | 52,214 | 62% | 27,905 | 82% | 10,960 | 84% | 7199 | 79% |
| Prior GFR <60 90+ d prior | 143,487 | 7% | N/A | N/A | 63,949 | 6% | 42,343 | 50% | 22,389 | 66% | 8941 | 69% | 5864 | 64% |
| Any UACR, UPCR, or UA | 811,462 | 39% | 128,244 | 14% | 585,936 | 59% | 56,305 | 67% | 24,789 | 73% | 9877 | 76% | 6305 | 69% |
| Any UACR | 140,256 | 7% | 2251 | 0.2% | 102,858 | 10% | 18,758 | 22% | 10,224 | 30% | 4073 | 31% | 2090 | 23% |
| No. UACR measurements | 2.0 | 2.9 | 0.9 | 1.2 | 2.0 | 2.6 | 2.5 | 3.2 | 2.7 | 3.6 | 2.9 | 4.2 | 2.3 | 3.9 |
| Most recent UACR, mg/g | ||||||||||||||
| <30 | 101,137 | 72% | 1773 | 79% | 81,015 | 79% | 12,139 | 65% | 5033 | 49% | 1030 | 25% | 146 | 7% |
| 30–300 | 28,637 | 20% | 357 | 16% | 18,105 | 13% | 4963 | 27% | 3420 | 34% | 1380 | 34% | 412 | 20% |
| >300 | 10,482 | 8% | 121 | 5% | 3738 | 3% | 1656 | 9% | 1771 | 17% | 1663 | 41% | 1532 | 73% |
| Any UPCR | 68,131 | 3% | 1910 | 0.2% | 41,646 | 4% | 9245 | 11% | 7658 | 23% | 4673 | 36% | 2998 | 33% |
| No. UPCR measurements | 2.3 | 5.2 | 1.1 | 3.0 | 1.9 | 4.3 | 3.0 | 6.4 | 3.5 | 7.7 | 3.7 | 6.6 | 3.6 | 7.3 |
| Most recent UPCR, mg/g | ||||||||||||||
| <150 | 30,932 | 45% | 838 | 44% | 21,755 | 52% | 4600 | 50% | 2820 | 34% | 780 | 17% | 138 | 5% |
| 150–500 | 21,952 | 32% | 638 | 33% | 14,027 | 34% | 2907 | 31% | 2639 | 35% | 1398 | 30% | 343 | 11% |
| >500 | 15,247 | 22% | 434 | 23% | 5864 | 14% | 1738 | 19% | 2199 | 29% | 2495 | 53% | 2517 | 84% |
| Any UA | 754,379 | 36% | 125,792 | 13% | 541,761 | 54% | 50,852 | 60% | 21,967 | 65% | 8461 | 65% | 5541 | 60% |
| No. UA measurements | 2.8 | 5.2 | 1.4 | 2.6 | 3.3 | 5.4 | 4.2 | 7.0 | 5.1 | 8.3 | 5.7 | 9.6 | 5.8 | 11.5 |
| Most recent UA | ||||||||||||||
| Negative | 589,612 | 78% | 97,753 | 78% | 436,605 | 81% | 37,424 | 74% | 13,717 | 62% | 3516 | 42% | 594 | 11% |
| Trace to 30 (trace, 1+) | 118,870 | 16% | 20,951 | 17% | 80,438 | 15% | 9226 | 18% | 4977 | 23% | 2206 | 26% | 1071 | 19% |
| 100 to >300 (2+, 3+, 4+) | 45,608 | 6% | 7072 | 6% | 24,545 | 5% | 4174 | 8% | 3244 | 15% | 2712 | 32% | 3860 | 70% |
| Dialysis | 26,766 | 1% | 4562 | 0.5% | 5696 | 0.6% | 3518 | 4% | 3258 | 10% | 3059 | 24% | 6672 | 73% |
| Transplant | 12,765 | 0.6% | 810 | 0.1% | 4818 | 0.5% | 2699 | 3% | 2166 | 6% | 1182 | 9% | 1089 | 12% |
N/A, not applicable; UACR, urine albumin-to-creatinine ratio; UPCR, urine protein-to-creatinine ratio; UA, urine albumin.